BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Cormorant Pharmaceuticals is defunct.

Fate: Acquired by BMS, July 2016, $95M + $425M milestones


------------------
If you believe any of this information is incorrect, please let us know.